Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers September 22, 2017
Pharmacy Choice - News - Over-the-Counter Drugs - September 22, 2017

Pharmacy News

 Over-the-Counter Drugs
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 242     Next >>     Go To Page:

8/23/17 - Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Additional Criteria and Procedures...
All comments should be identified with the OMB control number 0910-0688. Also include the FDA docket number found in brackets in the heading of this document. SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, FDA has submitted the following proposed collection of information to OMB for review and clearance. Specifically, FDA regulations
8/22/17 - FDA Commissioner Issues Statement on Prescription Opioid Medications Approved for Children
There's perhaps no more important mandate that we have at the FDA than safeguarding the health and safety of children. At a roundtable earlier this year, the FDA heard from professional groups, including the American Academy of Pediatrics and the American Academy of Family Physicians, about the use of cough suppressants, and in particular opioid co
8/22/17 - FDA evaluates prescription opioid medications approved for children
The FDA has heard from professional groups, including the American Academy of Paediatrics about the use of opioid cough suppressants for children...
8/22/17 - Health and Human Services Department (HHS); Food and Drug Administration (FDA) (F.R. Page 35965) - Webinar
EVENT: Health and Human Services Department; Food and Drug Administration holds a meeting by webinar to provide a status update on the process of FDA and industry discussions on an Over-the-Counter Monograph user fee program that began in July 2016.
8/22/17 - IntriCon Backs President's Signing of FDA Reauthorization Act into Law
IntriCon Corporation, a designer, developer, manufacturer and distributor of miniature and micro-miniature body-worn devices, announced that on Friday, August 18, 2017, President Donald Trump signed into law H.R. 2430, the U.S. Food and Drug Administration Reauthorization Act, which includes the Over-the-Counter Hearing Aid Act of 2017.
8/22/17 - NetworkNewsBreaks SeeThruEquity Updates Coverage on Innovus Pharmaceuticals, Inc. (INNV)
SeeThruEquity has updated its coverage and maintained its price target of $0.65 on shares of Innovus Pharmaceuticals, Inc. s stock following the company s report of financial results for the second quarter of 2017. Headquartered in San Diego, Innovus Pharma is an emerging over-the-counter consumer goods and specialty pharmaceutical company en
8/22/17 - Perrigo Announces Final FDA Approval and Settlement for the Store Brand OTC Equivalent of Nexium 24HR Capsules
Release date- 21082017- DUBLIN- Perrigo Company plc today announced that it has received final approval from the U.S. Food& Drug Administration for the store brand OTC equivalent of Nexium 24 HR capsules. The company also announced that it has reached a settlement of patent litigation with AstraZeneca allowing for the store brand OTC equivalent of
8/22/17 - President Signs Rep. Buchanan-Backed Hearing Aid Bill
Vern Buchanan, R- Fla., issued the following news release:. Congressman Vern Buchanan today announced that legislation he co-sponsored to make hearing aids more affordable for millions of Americans has been signed into law. The legislation was included in a broader bill to fund the Food and Drug Administration, which President Trump signed into law
8/22/17 - SeeThruEquity Issues Update on Innovus Pharmaceuticals (INNV) and Maintains Price Target of $0.65
NEW YORK, NY/ ACCESSWIRE/ August 22, 2017/ SeeThruEquity, a leading independent equity research and corporate access firm focused on small-cap and micro-cap public companies, today announced it has issued an update on Innovus Pharmaceuticals, Inc. and maintained its price target of $0.65. Innovus Pharmaceuticals, Inc. is a fast-growing commercial s
8/22/17 - Senator Hassan's Bipartisan Opioid Addiction Risk Transparency Act Signed Into Law as Part of FDA Bill
WASHINGTON- Last week, President Trump signed the Food and Drug Administration Reauthorization Act of 2017 into law, which included two measures championed by Senator Maggie Hassan. The FDA Reauthorization bill included the bipartisan Opioid Addiction Risk Transparency Act, which Senator Hassan authored with Senator Todd Young, and takes important
8/22/17 - Statement from FDA Commissioner Scott Gottlieb, M.D. - FDA is carefully evaluating prescription opioid medications approved to treat cough in children
Release date- 21082017- There's perhaps no more important mandate that we have at the FDA than safeguarding the health and safety of children. At a roundtable earlier this year, the FDA heard from professional groups, including the American Academy of Pediatrics and the American Academy of Family Physicians, about the use of cough suppressants, and
8/21/17 - Developing OTC syrup packaging for the highly regulated EU market
The regulatory environment has a great impact on business, especially in healthcare. Non-compliance exposes companies to the risk of launch delay, delisting products from the market and out-of-stocks. Moreover, it can cause reputational damage affecting staff, consumer and shareholder confidence, reduce market opportunities, and affect the bottom l
8/21/17 - Grassley Co-sponsored Bipartisan Over-the-Counter Hearing Aid Act Becomes Law
The Over-the-Counter Hearing Aid Act became law as part of the Food and Drug Administration Reauthorization Act. The bicameral measure requires the FDA to write regulations ensuring that the new category of over-the-counter hearing aids meets the same high standards for safety, consumer labeling and manufacturing protections as all medical devices,
8/21/17 - Health and Human Services Department (HHS); Food and Drug Administration (FDA) (F.R. Page 35965) - Webinar
EVENT: Health and Human Services Department; Food and Drug Administration holds a meeting by webinar to provide a status update on the process of FDA and industry discussions on an Over-the-Counter Monograph user fee program that began in July 2016.
8/21/17 - Perrigo Announces Final FDA Approval And Settlement For The Store Brand OTC Equivalent Of Nexium 24HR Capsules
Perrigo Company plc today announced that it has received final approval from the U.S. Food& Drug Administration for the store brand OTC equivalent of Nexium 24 HR capsules. Perrigo Executive Vice President and President, Consumer Healthcare Americas Jeff Needham stated, "This final approval and upcoming launch demonstrates the tremendous capab
8/21/17 - Statement from FDA Commissioner Scott Gottlieb, M.D. - FDA is carefully evaluating prescription opioid medications approved to treat cough in children
There's perhaps no more important mandate that we have at the FDA than safeguarding the health and safety of children. At a roundtable earlier this year, the FDA heard from professional groups, including the American Academy of Pediatrics and the American Academy of Family Physicians, about the use of cough suppressants, and in particular opioid co
8/21/17 - Vets First Choice Announces Two Strategic Acquisitions in Specialty Pharmacy Market
By a News Reporter-Staff News Editor at Pharma Business Week Vets First Choice, the leading provider of technology enabled healthcare solutions for veterinary practices, announced that its parent company, Direct Vet Marketing, has acquired Roadrunner Pharmacy and Atlas Pharmaceuticals. Roadrunner Pharmacy is the leading specialty compounding...
8/21/17 - Wearable ultrasound medical device manufacturing expands in United States to meet healthcare system demand for innovative musculoskeletal pain therapy.
TRUMBULL, CT- 21 Aug, 2017- ZetrOZ Systems, LLC, announced today that the company has expanded US-based production capability of its' innovative FDA cleared wearable-active ultrasound device- called sam Sport- used widely by pain management physicians, orthopedists, and the veteran's administration health system to address chronic back pain, joi
8/20/17 - Regional GlaxoSmithKline chief reveals how new pharma is changing Gulf health care [Arab News (Saudi Arabia)]
What the critics call big pharma has had an image problem in recent years, and Andrew Miles, the executive in charge of the global health care company GlaxoSmithKline s business in the Gulf, thinks he knows how to resolve it. Choice of medication should be a clinical choice, rather than being based on some potential conflict of interest
8/19/17 - President Trump Signs OTC Hearing Aid Legislation into Law
On Friday, August 18, President Donald Trump signed into law today the Food and Drug Administration Reauthorization Act of 2017, legislation that includes the Over the Counter Hearing Aid Act designed to provide greater public accessibility and affordability with over-the-counter (OTC) hearing aids. FDA will now be charged with creating and regula
8/19/17 - Q: My son has started teething
Q: My son has started teething, and I'd like to ease his discomfort. However, tests recently performed by the Food and Drug Administration on tablets by Hyland, a well-known maker of homeopathic products, revealed inconsistent amounts of belladonna, sometimes more than was listed on the label. The FDA asked Hyland to voluntarily recall its teething
8/18/17 - From Threat to Opportunity: Study Shows Cigarette Makers Shifted Stance on Nicotine Patches, Gum
The University of California's San Francisco campus issued the following news release:. "The industry has long taken a broad view of all nicotine products as a way to support smoking," said senior author Stanton Glantz, PhD, a UCSF professor of medicine and director of the UCSF Center for Tobacco Control Research and Education. " Our study shows t
8/18/17 - KONARED CORP - 10-Q - MANAGEMENTS' DISCUSSION AND ANALYSIS OR PLAN OF OPERATION
Certain information included herein contains forward-looking statements that involve risks and uncertainties within the meaning of Sections 27 A of the Securities Act, as amended; Section 21 E of the Securities Exchange Act of 1934. The factors that might cause such differences include, among others, the following: we have incurred significant loss
8/18/17 - Opioid Use Rarely Caused by Surgery Starts with Surgery Opioid Surgery Addiction HtkyLong-Term Opioid Use Rarely Starts with Surgery, Study Finds
Don t blame the nation s surgeons for an opiate-abuse crisis that now claims 142 lives daily in the United States. New research suggests that patients leaving the hospital after surgeries or inpatient procedures are rarely the ones whose long-term opioid use started with a doctor s prescription. Instead, the patients who most frequently go
8/18/17 - Patent Issued for Pharmaceutical Compositions and Methods of Use of 4-Pregenen-11.Beta.-17-21-Triol-3,20-Dione Derivatives (USPTO 9717743)
By a News Reporter-Staff News Editor at Drug Week ALLERGAN, INC. has been issued patent number 9717743, according to news reporting originating out of Alexandria, Virginia, by NewsRx editors. The patent's inventors are Edelman, Jeffrey L.; Nehme, Alissar. This patent was filed on September 12, 2014 and was published online on August 1, 2017.
Articles(s): 1 - 25 of 242     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415